c-MET (Protein | Antibody | cDNA Clone | ELISA Kit)

All c-MET reagents are produced in house and quality controlled, including 24 c-MET Antibody, 2 c-MET ELISA, 52 c-MET Gene, 11 c-MET Lysate, 12 c-MET Protein, 3 c-MET qPCR. All c-MET reagents are ready to use.

c-MET Background

Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that has been shown to be overexpressed and/or mutated in a variety of malignancies. HGFR protein is produced as a single-chain precursor, and HGF is the only known ligand. Normal HGF/HGFR signaling is essential for embryonic development, tissue repair or wound healing, whereas aberrantly active HGFR has been strongly implicated in tumorigenesis, particularly in the development of invasive and metastatic phenotypes. HGFR protein is a multifaceted regulator of growth, motility, and invasion, and is normally expressed by cells of epithelial origin. Preclinical studies suggest that targeting aberrant HGFR signaling could be an attractive therapy in cancer.

c-MET References

  • McGill GG, et al. (2006) c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem. 281(15): 10365-73.
  • Garcia S, et al. (2007) c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. British journal of cancer. 96(2): 329-35.
  • Socoteanu MP, et al. (2008) c-Met targeted therapy of cholangiocarcinoma. World J Gastroenterol. 14(19): 2990-4.
  • Kong DS, et al. (2009) Prognostic significance of c-Met expression in glioblastomas. Cancer. 115(1): 140-8.
彩票大奖得主捐赠 黑龙江6 1体彩开奖结果 七星彩一等奖多少钱 北京快3一定牛一定牛 三分pk拾稳赚方法 广东快乐十分遗漏数据 管家婆一波中特已公开 北京快3手机版 云南铜业股票行情 快3正规平台 破解11选5的密码出号